학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 342건 | 목록 1~10
Academic Journal
Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: joyce_liu@dfci.harvard.edu.; Xiong N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Wenham RM; Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL, United States of America.; Wahner-Hendrickson A; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States of America.; Armstrong DK; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States of America.; Chan N; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States of America.; O'Malley DM; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States of America.; Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America.; Penson RT; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, United States of America.; Cristea MC; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States of America.; Abbruzzese JL; Department of Medical Oncology, Duke Cancer Institute, Durham, NC, United States of America.; Matsuo K; Department of Obstetrics & Gynecology, Keck School of Medicine of University of Southern California, Los Angeles, CA, United States of America.; Olawaiye AB; Department of OBGYN, University of Pittsburgh Medical Center, Pittsburgh, PA, United States of America.; Barry WT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Cheng SC; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Polak M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Swisher EM; Department of Obstetrics & Gynecology, University of Washington, Seattle, WA, United States of America.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Kohn EC; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America; Clinical Investigations Branch, NCI Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States of America.; Ivy SP; Investigational Drug Branch, NCI Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States of America.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Academic Journal
Corcoran RB; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Do KT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kim JE; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Parikh AR; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Yeku OO; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Xiong N; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weekes CD; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Veneris J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ahronian LG; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Mauri G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, and Department of Hematology Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Tian J; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Norden BL; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Michel AG; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Van Seventer EE; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Siravegna G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Camphausen K; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Chi G; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Fetter IJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Chen H; National Institute of Health, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Bethesda, Maryland.; Takebe N; National Institute of Health, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Bethesda, Maryland.; Penson RT; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Juric D; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Flaherty KT; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Sullivan RJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Clark JW; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Heist RS; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cheng SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lee EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; da Costa AABA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA.; Gulhan D; Department of Biomedical Informatics and Ludwig Center at Harvard, Harvard Medical School, Boston, MA.; Wahner Hendrickson AE; Department of Medical Oncology, Mayo Clinic, Rochester, MN.; Kochupurakkal B; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA.; Kolin DL; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Kohn EC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.; Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Penson RT; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA.; Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Curtis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Sawyer H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Polak M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chowdhury D; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA.; Färkkilä A; Research Program in Systems Oncology, FIMM and HiLife, University of Helsinki, Helsinki, Finland.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Hirschl N; Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.; Leveque W; Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.; Granitto J; Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.; Sammarco V; Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.; Fontillas M; Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.; Penson RT; Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Arend RC; University of Alabama at Birmingham School of Medicine, Birmingham, AL.; Monk BJ; HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ.; Shapira-Frommer R; Chaim Sheba Medical Center, Ramat Gan, Israel.; Haggerty AF; Hospital of the University of Pennsylvania, Philadelphia, PA.; Alvarez EA; University of California, San Francisco, CA.; Amit A; Rambam Health Care Campus, Haifa, Israel.; Alvarez Secord A; Duke Cancer Institute, Duke University Health System, Durham, NC.; Muller C; University of New Mexico, Albuquerque, NM.; Casado Herraez A; San Carlos University Teaching Hospital, Madrid, Spain.; Herzog TJ; University of Cincinnati Cancer Center, University of Cincinnati, Cincinnati, OH.; Tewari KS; University of California, Medical Center, Orange, CA.; Cohen JG; Department of Surgery, City of Hope, Irvine, CA.; Huang M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Yachnin A; Kaplan Medical Center, Rehovot, Israel.; Holeman LL; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK.; Ledermann JA; UCL Cancer Institute, University College London, London, United Kingdom.; Rachmilewitz Minei T; VBL Therapeutics, Modiin, Israel.; Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium.; Fain Shmueli S; VBL Therapeutics, Modiin, Israel.; Lavi M; VBL Therapeutics, Modiin, Israel.; Harats D; VBL Therapeutics, Modiin, Israel.; Penson RT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Drew Y; Department of Medical Oncology, BC Cancer - Vancouver and University of British Columbia, Vancouver, British Columbia, Canada.; Kim JW; Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.; Penson RT; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts.; O'Malley DM; Division of Gynecology Oncology, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.; Parkinson C; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Roxburgh P; Medical Oncology, Beatson West of Scotland Cancer Centre, and School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Plummer R; Translational and Clinical Research Institute, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Newcastle University, Newcastle upon Tyne, United Kingdom.; Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.; Imbimbo M; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.; Ferguson M; Department of Oncology, NHS Tayside, Ninewells Hospital, Dundee, United Kingdom.; Rosengarten O; Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kim MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.; Gal-Yam E; Chaim Sheba Medical Center, Tel HaShomer, Israel.; Tsoref D; Rabin Medical Center-Beilinson Campus, Petach Tikva and Tel-Aviv University, Tel-Aviv, Israel.; Kim JH; Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; You B; Service d'Oncologie Médicale, CITOHL, EPSLYON, Institut de Cancérologie des Hospices Civils de Lyon, IC-HCL, Université Claude Bernard Lyon 1, Lyon, France.; De Jonge M; Department of Medical Oncology, Erasmus Medisch Centrum, Rotterdam, the Netherlands.; Lalisang R; Division of Medical Oncology, Department of Internal Medicine, GROW - School of Oncology and Reproduction, Maastricht UMC+ Comprehensive Cancer Center, Maastricht University Medical Centre, Maastricht, the Netherlands.; Gort E; Department of Medical Oncology, UMC Utrecht, Utrecht, the Netherlands.; Bastian S; Medical Oncology and Haematology, Kantonsspital Graubuenden, Chur, Switzerland.; Meyer K; Late Development Oncology, Oncology R&D, AstraZeneca, Gaithersburg, Maryland.; Feeney L; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Baker N; Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom.; Ah-See ML; Late-stage Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, Pennsylvania.; Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Pignata S; Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) and Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy. Electronic address: s.pignata@istitutotumori.na.it.; Bookman M; Gynecologic Oncology Group Foundation (GOG-F) and Kaiser Permanente Northern California, San Francisco, CA, USA. Electronic address: Michael.A.Bookman@kp.org.; Sehouli J; Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe (AGO Study Group), Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (North-Eastern German Society of Gynaecologic Oncology; NOGGO) and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin, Germany. Electronic address: jalid.sehouli@charite.de.; Miller A; GOG-F and Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Austin.Miller@RoswellPark.org.; Penson RT; Massachusetts General Hospital, Boston, MA, USA. Electronic address: Penson.Richard@mgh.harvard.edu.; Taskiran C; Turkish Society of Gynecologic Oncology (TRSGO) and Koç University School of Medicine, Istanbul, Turkey; Vehbi Koç Vakfı American Hospital, Istanbul, Turkey. Electronic address: cagataytaskiran@yahoo.com.; Anderson C; GOG-F and Willamette Valley Cancer Institute, Eugene, OR, USA. Electronic address: Charles.Anderson@USONCOLOGY.COM.; Hietanen S; Nordic Society of Gynaecological Oncology (NSGO), Copenhagen, Denmark and Turku University Hospital, Turku, Finland. Electronic address: Sakari.Hietanen@tyks.fi.; Myers T; GOG-F and Baystate Medical Center, Springfield, MA, USA. Electronic address: tashanna.myersmd@baystatehealth.org.; Madry R; Department of Oncology, Poznań University of Medical Sciences, Poznań, Poland. Electronic address: radoslaw.madry@skpp.edu.pl.; Willmott L; GOG-F and Arizona Oncology Associates, PC, Phoenix, AZ, USA. Electronic address: lyndsay.willmott@arizonaccc.com.; Lortholary A; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du sein (GINECO) and Hôpital Privé du Confluent, Nantes, France. Electronic address: ALAIN.LORTHOLARY@groupeconfluent.fr.; Thomes-Pepin J; GOG-F and Minnesota Oncology, Maplewood, MN, USA. Electronic address: Jessica.ThomesPepin@usoncology.com.; Aghajanian C; GOG-F and Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: aghajanc@MSKCC.ORG.; McCourt C; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, Saint Louis, MO, USA. Electronic address: cmccourt@wustl.edu.; Stuckey A; The Warren Alpert Medical School, Brown University, Providence, RI, USA. Electronic address: AStuckey@Wihri.org.; Wu X; Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. Electronic address: wu.xh@fudan.edu.cn.; Nishio S; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan. Electronic address: shinshin@med.kurume-u.ac.jp.; Copeland LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, Columbus, OH, USA. Electronic address: Larry.Copeland@osumc.edu.; He Y; Global Data Operations, Functional Service Provider, Parexel International, Chengdu, China. Electronic address: yvette.he@businesspartner.roche.com.; Molinero L; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA. Electronic address: molinero.luciana@gene.com.; Patel S; Patient-Centered Outcomes Research, Genentech, Inc., South San Francisco, CA, USA. Electronic address: patel.sheetal@gene.com.; Lin YG; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA. Electronic address: lin-liu.yvonne@gene.com.; Khor VK; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA. Electronic address: khor.victor@gene.com.; Moore KN; GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Sarah Cannon Research Institute, Nashville, TN, USA. Electronic address: Kathleen-Moore@ouhsc.edu.
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Penson, RT
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어